David Chromy

1.4k total citations
48 papers, 688 citations indexed

About

David Chromy is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, David Chromy has authored 48 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 33 papers in Hepatology and 8 papers in Surgery. Recurrent topics in David Chromy's work include Hepatitis C virus research (28 papers), Liver Disease Diagnosis and Treatment (26 papers) and Liver Disease and Transplantation (11 papers). David Chromy is often cited by papers focused on Hepatitis C virus research (28 papers), Liver Disease Diagnosis and Treatment (26 papers) and Liver Disease and Transplantation (11 papers). David Chromy collaborates with scholars based in Austria, Germany and United States. David Chromy's co-authors include Thomas Reiberger, Mattias Mandorfer, Michael Trauner, Philipp Schwabl, Markus Peck‐Radosavljevic, Péter Ferenci, Albert Friedrich Stättermayer, K Kozbial, Arnulf Ferlitsch and Theresa Bucsics and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

David Chromy

42 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Chromy Austria 12 619 617 91 70 28 48 688
Alexander R. Bonnel United States 4 224 0.4× 231 0.4× 79 0.9× 66 0.9× 29 1.0× 5 332
Simon Siu‐Man Sum China 13 584 0.9× 534 0.9× 22 0.2× 65 0.9× 11 0.4× 22 647
Josep Llach Spain 5 247 0.4× 293 0.5× 133 1.5× 55 0.8× 21 0.8× 6 351
Steven Shev Sweden 10 359 0.6× 360 0.6× 45 0.5× 51 0.7× 4 0.1× 11 453
Sara McGeorge United States 11 221 0.4× 179 0.3× 71 0.8× 175 2.5× 12 0.4× 18 385
R Baumgaŕten Germany 8 375 0.6× 387 0.6× 22 0.2× 66 0.9× 16 0.6× 30 481
Giuseppe Barbaro Italy 8 261 0.4× 245 0.4× 11 0.1× 62 0.9× 15 0.5× 9 356
Mario Magnone United States 6 236 0.4× 156 0.3× 57 0.6× 85 1.2× 8 0.3× 14 364
X.‐M. Li United States 9 313 0.5× 261 0.4× 45 0.5× 76 1.1× 2 0.1× 9 559
Wen‐Ling Huang Taiwan 11 434 0.7× 388 0.6× 40 0.4× 96 1.4× 7 0.3× 15 581

Countries citing papers authored by David Chromy

Since Specialization
Citations

This map shows the geographic impact of David Chromy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chromy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chromy more than expected).

Fields of papers citing papers by David Chromy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chromy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chromy. The network helps show where David Chromy may publish in the future.

Co-authorship network of co-authors of David Chromy

This figure shows the co-authorship network connecting the top 25 collaborators of David Chromy. A scholar is included among the top collaborators of David Chromy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chromy. David Chromy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chromy, David, A. N. Okoro, Katharina Grabmeier‐Pfistershammer, et al.. (2024). Asymptomatic lymphogranuloma venereum is commonly found among men who have sex with men in Austria. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(3). 389–397. 3 indexed citations
2.
Chromy, David, Alexander Indra, Patrick Hyden, et al.. (2024). Genotypic cluster analysis of Neisseria gonorrhoeae reveals a spectrum of sexual mixing including among HIV-serodiscordant men who have sex with men. Infectious Diseases. 56(9). 712–721.
3.
Koren, Anna, Mathias Drach, Juan M. Sánchez‐Guzmán, et al.. (2024). Combination of compound screening with an animal model identifies pentamidine to prevent Chlamydia trachomatis infection. Cell Reports Medicine. 5(7). 101643–101643. 1 indexed citations
4.
Chromy, David. (2023). Preisträger stellen sich vor: David Chromy erhält das Clinician Scientist Research Fellowship in Dermatovenereology der ÖGDV 2022. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(7). 825–826. 1 indexed citations
5.
Schmidbauer, Victor, Heimo Lagler, Stefan Stremitzer, et al.. (2023). Diaphragmatic perforation as a result of cystic echinococcosis in an HIV-positive migrant. Journal of Travel Medicine. 30(6).
6.
Chromy, David, Steffi Silling, Ulrike Wieland, & Alexander Kreuter. (2023). Anogenitalwarzen – ein Update. Die Dermatologie. 75(1). 30–39.
7.
Grabmeier‐Pfistershammer, Katharina, et al.. (2023). No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria. HIV Medicine. 25(1). 150–153. 1 indexed citations
8.
Bauer, David, Vladimir Matić, Ruxandra Mare, et al.. (2022). Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography. Ultraschall in der Medizin - European Journal of Ultrasound. 44(2). 169–178. 11 indexed citations
9.
Geusau, Alexandra, David Chromy, Claudia Eder, et al.. (2022). Resistance profiles of Neisseria gonorrhoeae isolates in Vienna, Austria: a phenotypic and genetic characterization from 2013 to 2020. International Journal of Antimicrobial Agents. 60(5-6). 106656–106656. 6 indexed citations
10.
Chromy, David, David Bauer, Victor Schmidbauer, et al.. (2022). Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up. Wiener klinische Wochenschrift. 135(15-16). 420–428. 2 indexed citations
11.
Semmler, Georg, Teresa Binter, K Kozbial, et al.. (2021). Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR. Journal of Personalized Medicine. 11(4). 281–281. 4 indexed citations
12.
Jachs, Mathias, Teresa Binter, David Chromy, et al.. (2021). Outcomes of an HCV elimination program targeting the Viennese MSM population. Wiener klinische Wochenschrift. 133(13-14). 635–640. 9 indexed citations
13.
Chromy, David, David Bauer, Benedikt Simbrunner, et al.. (2020). Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence. Wiener klinische Wochenschrift. 133(9-10). 452–460. 5 indexed citations
14.
Bauer, David, David Chromy, Benedikt Simbrunner, et al.. (2020). Recent outbreaks of severe hepatitis A virus infections in Vienna. European Journal of Clinical Microbiology & Infectious Diseases. 40(2). 335–344. 11 indexed citations
15.
Semmler, Georg, Bernhard Scheiner, Philipp Schwabl, et al.. (2019). The impact of hepatic steatosis on portal hypertension. PLoS ONE. 14(11). e0224506–e0224506. 11 indexed citations
16.
Chromy, David, Mattias Mandorfer, Theresa Bucsics, et al.. (2019). High efficacy of interferon‐free therapy for acute hepatitis C in HIV‐positive patients. United European Gastroenterology Journal. 7(4). 507–516. 22 indexed citations
17.
Chromy, David, Mattias Mandorfer, Theresa Bucsics, et al.. (2019). Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication. AIDS Patient Care and STDs. 33(5). 197–206. 10 indexed citations
18.
Simbrunner, Benedikt, Helmuth Haslacher, David Bauer, et al.. (2019). Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites. United European Gastroenterology Journal. 7(5). 651–661. 7 indexed citations
19.
Haider, Lukas, Mattias Mandorfer, Thomas Reiberger, et al.. (2018). Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI. Contrast Media & Molecular Imaging. 2018. 1–9. 8 indexed citations
20.
Mandorfer, Mattias, K Kozbial, Philipp Schwabl, et al.. (2016). Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension. Journal of Hepatology. 65(4). 692–699. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander R. Bonnel Breakdown of academic impact, for papers by Simon Siu‐Man Sum Breakdown of academic impact, for papers by Josep Llach Breakdown of academic impact, for papers by Steven Shev Breakdown of academic impact, for papers by Sara McGeorge Breakdown of academic impact, for papers by R Baumgaŕten Breakdown of academic impact, for papers by Giuseppe Barbaro Breakdown of academic impact, for papers by Mario Magnone Breakdown of academic impact, for papers by X.‐M. Li Breakdown of academic impact, for papers by Wen‐Ling Huang
Rankless by CCL
2026